UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Correction: Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner

The Journal of immunology (1950), 2018-04, Vol.200 (7), p.2509-2510

2018

Volltextzugriff (PDF)

Correction: Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis

PloS one, 2018-04, Vol.13 (4), p.e0195170-e0195170

2018

Volltextzugriff (PDF)

Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis

PloS one, 2012-01, Vol.7 (1), p.e28305-e28305

2012

Volltextzugriff (PDF)

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000218

2020

Volltextzugriff (PDF)

Self-reactive IgE exacerbates interferon responses associated with autoimmunity

Nature immunology, 2016-02, Vol.17 (2), p.196-203

2016

Volltextzugriff (PDF)

Abstract 1015: Directionality of T-cell-mediated cross-protection against the same tumor in lungs versus skin

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1015-1015

2017

Volltextzugriff (PDF)

Abstract 3636: Potent antitumor activity of duvortuxizumab, a CD19 x CD3 DART® molecule, in lymphoma models

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3636-3636

2017

Volltextzugriff (PDF)

Delicate Balance among Three Types of T Cells in Concurrent Regulation of Tumor Immunity

Cancer research (Chicago, Ill.), 2013-03, Vol.73 (5), p.1514-1523

2013

Volltextzugriff (PDF)

Abstract 3657: Cross-regulation between the two subsets of NKT cells is dependent on interferon-gamma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3657-3657

2014

Volltextzugriff (PDF)

Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner

The Journal of immunology (1950), 2010-01, Vol.184 (2), p.1092-1101

2010

Volltextzugriff (PDF)

Identification of sulfatide reactive type II NKT cells using CD1d dimers (P3291)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.211-211.3

2013

Volltextzugriff (PDF)

Abstract 1262: Identification of sulfatide reactive type II NKT cells using CD1d dimers

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1262-1262

2013

Volltextzugriff (PDF)

Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity

The Journal of clinical investigation, 2011-02, Vol.121 (2), p.683-694

2011

Volltextzugriff (PDF)

β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy

Clinical cancer research, 2013-08, Vol.19 (16), p.4404-4411

2013

Volltextzugriff (PDF)

Balance is a key for happiness

Oncoimmunology, 2013-05, Vol.2 (5), p.e24211-e24211

2013

Volltextzugriff (PDF)

Abstract 1556: α-mannosylceramide, a new NKT cell agonist, induces tumor immunity without anergy induction in NKT cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1556-1556

2012

Volltextzugriff (PDF)

A Novel Recombinant Fusion Protein Encoding a 20-Amino Acid Residue of the Third Extracellular (E3) Domain of CCR2 Neutralizes the Biological Activity of CCL2

The Journal of immunology (1950), 2009-07, Vol.183 (1), p.732-739

2009

Volltextzugriff (PDF)

Abstract 460: Delicate balance among three types of T cells in concurrent regulation of tumor immunity

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.460-460

2013

Volltextzugriff (PDF)

Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner

The Journal of immunology (1950), 2010-05, Vol.184 (9), p.5414-5414

2010

Volltextzugriff (PDF)

Abstract 4746: Type I NKT cells mediate anti-tumor immunity through a TNF-α- and NOS-dependent pathway when stimulated with β-ManCer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4746-4746

2011

Volltextzugriff (PDF)

Mouse and human iNKT cell agonist [Beta]-mannosylceramide reveals a distinct mechanism of tumor immunity

The Journal of clinical investigation, 2011-02, Vol.121 (2), p.683

2011

Volltextzugriff (PDF)

63 The Dual Role of CCL2 (MCP-1) in the Pathogenesis of Prostate Cancer

Cytokine (Philadelphia, Pa.), 2007-07, Vol.39 (1), p.18-18

2007

Volltextzugriff (PDF)

Applying Judgment Analysis Theory and Methods to Obtain an Insight Into Clinical Judgments: Implementation and Findings With a Simulated Neonatal Intensive Care Unit Setup

Simulation in healthcare : journal of the Society for Medical Simulation, 2016-06, Vol.11 (3), p.200-208

2016

Volltextzugriff (PDF)

Using Video Recorded Neonatal Intensive Care Unit Scenarios to Test Agreement between Clinicians’ Assessments

Proceedings of the Human Factors and Ergonomics Society Annual Meeting, 2014-09, Vol.58 (1), p.783-787

2014

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correction: Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner

Correction: Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis

Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Self-reactive IgE exacerbates interferon responses associated with autoimmunity

Abstract 1015: Directionality of T-cell-mediated cross-protection against the same tumor in lungs versus skin

Abstract 3636: Potent antitumor activity of duvortuxizumab, a CD19 x CD3 DART® molecule, in lymphoma models

Delicate Balance among Three Types of T Cells in Concurrent Regulation of Tumor Immunity

Abstract 3657: Cross-regulation between the two subsets of NKT cells is dependent on interferon-gamma

Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner

Identification of sulfatide reactive type II NKT cells using CD1d dimers (P3291)

Abstract 1262: Identification of sulfatide reactive type II NKT cells using CD1d dimers

Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity

β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy

Balance is a key for happiness

Abstract 1556: α-mannosylceramide, a new NKT cell agonist, induces tumor immunity without anergy induction in NKT cells

A Novel Recombinant Fusion Protein Encoding a 20-Amino Acid Residue of the Third Extracellular (E3) Domain of CCR2 Neutralizes the Biological Activity of CCL2

Abstract 460: Delicate balance among three types of T cells in concurrent regulation of tumor immunity

Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner

Abstract 4746: Type I NKT cells mediate anti-tumor immunity through a TNF-α- and NOS-dependent pathway when stimulated with β-ManCer

Mouse and human iNKT cell agonist [Beta]-mannosylceramide reveals a distinct mechanism of tumor immunity

63 The Dual Role of CCL2 (MCP-1) in the Pathogenesis of Prostate Cancer

Applying Judgment Analysis Theory and Methods to Obtain an Insight Into Clinical Judgments: Implementation and Findings With a Simulated Neonatal Intensive Care Unit Setup

Using Video Recorded Neonatal Intensive Care Unit Scenarios to Test Agreement between Clinicians’ Assessments

Suchergebnisse filtern